← back to search

Jingwen Wang

Shanghai Medical College of Fudan University · CN
🔎 Find collaborators in Pathology and Forensic Medicine · Immunology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pathology and Forensic Medicine · Immunology
Research interest
Research focused on Regimen and Neutropenia, with related work in Gastroenterology, Arsenic trioxide, Rituximab. Notable publications include 'Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China', 'Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial', and 'Primary breast diffuse large B‐cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure'.
h-index
citations
535
works
19
NIH funding
primary concept
email

Recent publications

Clinical outcomes and therapeutic modalities in older Chinese patients with MCL: a multi-center real-world retrospective study
Annals of Medicine 2025cited by 2position: middledoi
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China
Annals of Hematology 2024cited by 3position: middledoi
Multicenter Retrospective Cohort Study of 694 Patients with Ocular Adnexal Marginal Zone B-Cell Lymphoma on Behalf of the Chinese Ocular Lymphoma Collaborative Group (COLCG)
Blood 2024cited by 0position: middledoi
First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study
BMC Cancer 2023cited by 6position: middledoi
Biomechanical evaluation of the hybrid pedicle screw—cortical bone trajectory technique in transforaminal lumbar interbody fusion to adjacent segment degeneration—finite element analysis
BMC Musculoskeletal Disorders 2023cited by 6position: middledoi
Correction: Biomechanical evaluation of the hybrid pedicle screw—cortical bone trajectory technique in transforaminal lumbar interbody fusion to adjacent segment degeneration—finite element analysis
BMC Musculoskeletal Disorders 2023cited by 2position: middledoi
P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY
HemaSphere 2023cited by 0position: middledoi
Prednisone plus IVIg compared with prednisone or IVIg for immune thrombocytopenia in pregnancy: a national retrospective cohort study
Therapeutic Advances in Hematology 2022cited by 15position: middledoi
A phase II, multicenter, single-arm study of parsaclisib, a PI3Kδ inhibitor, in relapsed or refractory follicular lymphoma in China: Updated data from the study.
Journal of Clinical Oncology 2022cited by 0position: middledoi
The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
Cancer Biology and Medicine 2021cited by 30position: middledoi
Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the <scp>MONITOR</scp> model in a nationwide multicenter study
American Journal of Hematology 2021cited by 13position: middledoi
Combination of Chidamide with the CHOEP Regimen in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL): A Prospective, Multicenter, Single-Arm, Phase 1b/2 Trial
Blood 2019cited by 4position: middledoi
Risk factors of Roux-en-Y stasis syndrome after total gastrectomy
Chin Arch Gen Surg(Electronic Edition) 2019cited by 0position: middledoi
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial
The Lancet Oncology 2018cited by 144position: middledoi
Primary breast diffuse large B‐cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure
Cancer Science 2018cited by 44position: middledoi
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
Journal of Hematology & Oncology 2017cited by 251position: middledoi
[Clinical Features and Prognosis of t(8;21) AML Patients in China: A Multicenter Retrospective Study].
PubMed 2017cited by 3position: middledoi
Comparison of Clinical Efficacy of Cytarabine with Different Regimens in Postremission Consolidation Therapy for Adult t(8;21) AML Patients: A Multicenter Retrospective Study in China
Acta Haematologica 2016cited by 8position: middledoi
Primary Breast Diffuse Large B Cell Lymphoma in the Rituximab Era: Outcomes of a Multicenter Retrospective Study By the Lymphoma and Leukemia Committee of Chinese Geriatric Oncology Society(LLC-CGOS)
Blood 2016cited by 4position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Quanshun Wang · Chinese PLA General Hospital5 papers (2016–2024)Huilai Zhang · Tianjin Medical University Cancer Institute and Hospital5 papers (2019–2024) · 4 papers (2019–2024)Aichun Liu · Shandong University of Technology4 papers (2019–2024)Hongmei Jing · King University4 papers (2019–2025)Wei Zhang · Chinese Academy of Medical Sciences & Peking Union Medical College3 papers (2019–2024)Jianxia He · Shanxi Medical University3 papers (2019–2024)Yuhuan Gao · Hebei Medical University3 papers (2019–2024)Meiyun Fang · Dalian Medical University3 papers (2016–2018)Zengjun Li · West China Medical Center of Sichuan University3 papers (2019–2024)Owen A. O’Connor · Virginia Cancer Institute3 papers (2019–2024)Jianmin Luo · Hebei Medical University3 papers (2016–2024)Hui Liu · Nanjing University of Chinese Medicine3 papers (2016–2019)Lihong Liu · Hebei Medical University3 papers (2019–2024)Yi-Gai Ma · Shanxi Medical University2 papers (2016–2017)Hanqian Niu · Xinjiang Medical University2 papers (2023–2023)Xiaoyan Ke · Xuzhou Medical College2 papers (2016–2017)Li Yu · Jiangnan University2 papers (2016–2017)Hailong Guo · Guangdong University of Technology2 papers (2023–2023)Liping Su · Xiamen University2 papers (2019–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pathology and Forensic Medicine · Immunology →